(Total Views: 329)
Posted On: 07/02/2020 1:25:32 PM
Post# of 4861
Israel's move to legalize cannabis exports and decriminalize domestic cannabis has created an enormous opportunity for Israel-based cannabis firms. The country's prime minister, defense minister and police minister backed the easing of enforcement of existing laws-ostensibly referring to recreational cannabis use in the country.
Isracann Biosciences Inc. (CSE: IPOT) (OTC Pink: ISCNF) plans to capitalize on both of these opportunities. As a low-cost Israeli cannabis pure-play, the company is uniquely positioned to serve an undersupplied domestic market and new international markets with its fully-funded 230,000 sq. ft. production facility that's currently wrapping up development.
Unlike Canada and most of North America, Israel has ideal humidity and temperature with approximately 300 days of high-UV sun per day. These conditions are ideal for producing cannabis at one-third of the cost of growing in colder climates, while multiple growing cycles enable higher production per square foot-creating better revenue and margins.
Isracann Biosciences Inc. (CSE: IPOT) (OTC Pink: ISCNF) plans to capitalize on both of these opportunities. As a low-cost Israeli cannabis pure-play, the company is uniquely positioned to serve an undersupplied domestic market and new international markets with its fully-funded 230,000 sq. ft. production facility that's currently wrapping up development.
Unlike Canada and most of North America, Israel has ideal humidity and temperature with approximately 300 days of high-UV sun per day. These conditions are ideal for producing cannabis at one-third of the cost of growing in colder climates, while multiple growing cycles enable higher production per square foot-creating better revenue and margins.
(2)
(0)Scroll down for more posts ▼
